Personalized Medicine Drives DNA Microarray Market Growth: The Driving Engine Behind DNA Microarray Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

DNA Microarray Market Size Growth Forecast: What to Expect by 2025?
The growth of the DNA microarray market has been swift in recent years. The market is predicted to escalate from a worth of $3.38 billion in 2024 to $3.79 billion in 2025, increasing at a compound annual growth rate (CAGR) of 12.3%. The observable expansion during the past years can be credited to factors such as the rise of pharmacogenomics, the development of healthcare infrastructure, the establishment of collaborations and partnerships, the reduction of costs, and an increase in public knowledge and awareness.

How Will the DNA Microarray Market Size Evolve and Grow by 2029?
Growth is expected to accelerate in the DNA microarray market over the coming years, with predictions indicating it will reach a worth of $5.98 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.1%. This anticipated growth over the forecast period is associated with the development of personalized medicine, the introduction of comparative genomic hybridization (CGH), the widening of agricultural genomics, official authorisations and guidelines, and an increasing occurrence of chronic illnesses. The forecast period is also expected to be marked by advancements in genomic research, an increase in funding for genomic investigations, technological innovations, amalgamation with other technologies, and technological enhancements.

View the full report here:
https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

What Drivers Are Propelling the Growth of DNA Microarray Market Forward?
The DNA microarray market is expected to experience robust growth due to the increasing utilization of personalized medicine. This type of medicine customizes medical treatments based on the unique characteristics of each patient, taking into consideration their genetic factors, environmental conditions, and lifestyle habits, to maximize treatment efficiency and results. This movement towards personalized medicine has been propelled by the rapid advancement of 'omics' technologies, data amalgamation, genetics, and a heightened understanding of the importance of individualized patient prescriptions and preventative measures. DNA microarrays facilitate personalized medicine by scrutinizing gene expression patterns, permitting individualized treatment strategies determined by an individual's genetic makeup. For example, as stated by the US-based non-profit organization the Personalized Medicine Coalition, in February 2024, the FDA sanctioned 16 new personalized treatments for those suffering from uncommon diseases in 2023, a significant increase from the 6 approved in 2022. Consequently, the burgeoning use of personalized medicine is fueling the growth of the DNA microarray market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16039&type=smp

Which Emerging Trends Are Transforming the DNA Microarray Market in 2025?
Leading corporations in the DNA microarray sector are investing in cutting-edge technology development, specifically ones that boast a two-day turnaround time to secure an advantage over their competitors. The swift and comprehensive results obtained from microarray analysis can accelerate both research and clinical decisions. In August 2023, for example, Thermo Fisher Scientific Inc., an American biotech company, debuted the Applied Biosystems CytoScan HD Accel array. This new chromosomal microarray set a new standard in cytogenetic research labs, improving productivity, efficiency, and profitability with its remarkable two-day turnaround time. The CytoScan HD Accel array undertakes whole-genome analysis, enhancing coverage in more than 5,000 crucial genomic regions. This paves the way for greater understanding of chromosomal variants useful in various domains, including prenatal, postnatal, and cancer research.

What Are the Key Segments in the DNA Microarray Market?
The DNA microarray market covered in this report is segmented -

1) By Type: Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Other Types
2) By Application: Gene Expression Analysis, Genotyping, Other Applications
3) By End-user: Pharmaceutical And Biotechnology Companies, Diagnostic Centers, Hospitals And Clinics, Academic And Research Institute, Other End-Users

Subsegments:
1) By Complementary DNA Microarrays: Gene Expression Profiling, Comparative Genomic Hybridization (CGH), Quantitative Analysis
2) By Oligonucleotide DNA Microarrays: Gene Expression Microarrays, Single Nucleotide Polymorphism (SNP) Arrays, DNA Methylation Arrays, Pathogen Detection Arrays
3) By Other Types: Protein-DNA Microarrays, Tissue Microarrays, Affinity Microarrays, Spotted DNA Microarrays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16039&type=smp

Who Are the Key Players Shaping the DNA Microarray Market's Competitive Landscape?
Major companies operating in the DNA microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

What Geographic Markets Are Powering Growth in the DNA Microarray Market?
North America was the largest region in the DNA microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16039

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.